D-dimer levels correlate with pathologic thrombosis in trauma patients.

Area of Science:

• Trauma care
• Hematology
• Diagnostic markers

Background:

• Pathologic thrombosis, including pulmonary embolism (PE) and deep venous thrombosis (DVT), is a major cause of morbidity and mortality in trauma patients.
• Associated conditions in trauma patients complicate the diagnosis and treatment of thrombosis.
• Hypercoagulability is a key risk factor for developing pathologic thrombosis.

Purpose of the Study:

• To evaluate D-dimer crosslinked fibrin degradation products (D-dimer XDPs) as an indicator of hypercoagulability and thrombosis risk in trauma patients.
• To analyze the time course of D-dimer XDP levels following trauma.
• To determine if a secondary rise in D-dimer XDP levels predicts the development of pathologic thrombosis.

Main Methods:

• Study included 41 trauma patients, divided into two groups.
• Monitored D-dimer XDP levels over time after trauma.
• Correlated D-dimer XDP levels with the occurrence of PE and DVT.

Main Results:

• A secondary increase in D-dimer XDP levels was observed in patients who developed PE.
• Sepsis and adult respiratory distress syndrome can also cause a late increase in D-dimer XDP levels.
• D-dimer determinations offer a simple and cost-effective method for risk assessment.

Conclusions:

• A secondary rise in D-dimer XDP levels is a potential indicator of pathologic thrombosis risk in trauma patients.
• D-dimer XDP measurement provides an accessible tool for evaluating hypercoagulability post-trauma.
• Further investigation may refine the utility of D-dimer in managing thrombosis risk in this population.